Hepatitis C Virus Envelope Glycoprotein Signatures Are Associated With Treatment Failure and Modulation of Viral Entry and Neutralization

Autor: Mirjam B. Zeisel, François Habersetzer, John E. Tavis, Samira Fafi-Kremer, John M. Murray, Aurélie Velay, Anne-Claire Erba, Jean-Pierre Gut, Isabel Fofana, Evelyne Schvoerer, Rémy Moenne-Loccoz, Maureen J. Donlin, Marine Turek, Françoise Stoll-Keller, Michel Doffoel, Thomas F. Baumert

Publikováno v: Journal of Infectious Diseases
Journal of Infectious Diseases, 2013, 207 (8), pp.1306-1315. ⟨10.1093/infdis/jit032⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2013, 207 (8), pp.1306-1315. ⟨10.1093/infdis/jit032⟩

BACKGROUND: A major challenge for antiviral treatment of hepatitis C virus (HCV) infection is viral resistance, potentially resulting from the high variability of HCV envelope glycoproteins and subsequent selection of strains with enhanced infectivit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482a55b1d433630d98fb1aafd6fce2ed
https://hal.univ-lorraine.fr/hal-02014345